Apr 21, 2022 / 12:00PM GMT
Operator
Hello, everyone, and welcome to Hansa Biopharma First Quarter 2022 Conference Call. My name is Juan, and I will be coordinating your call today. (Operator Instructions)
Now I will hand over to your host, Soren Tulstrup, CEO of Hansa Biopharma. Please Soren, go ahead.
Søren Tulstrup - Hansa Biopharma AB(publ)-President&CEO
Thank you, operator. Good afternoon, good morning, and welcome to the Hansa Biopharma first quarter 2022 conference call.
I'm Soren Tulstrup, CEO of Hansa Biopharma. And joining me today is Hansa's Head of Investor Relations, Klaus Sindahl. Our CFO, Donato Spota, was also scheduled to join us today. However, as his wife is giving birth as we speak, he's heavily engaged in the labor room of the local hospital, and we're sending him our best wishes.
Hansa's mission is to preserve and improve human life, and a necessary enabler to deliver on this mission is, obviously, that someone takes care of giving life. And so I'd like to compliment Donato
Q1 2022 Hansa Biopharma AB Earnings Call Transcript
Apr 21, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers